Los Angeles Times

Capping years of criticism, Purdue Pharma will stop promoting its opioid drugs to doctors

The manufacturer of the powerful painkiller OxyContin announced this week that it will stop promoting its opioid drugs to doctors after years of criticism and mounting lawsuits, some based in part on a Los Angeles Times investigation.

Connecticut-based Purdue Pharma informed its employees that it was cutting its sales force in half, leaving about 200 representatives in the U.S., who no longer will visit doctors' offices to discuss the company's opioid products.

"We have restructured and significantly reduced our commercial operation and will no longer be promoting opioids to prescribers," the company said in a statement. "Going forward, questions and requests for information about our opioid products will be handled through direct communications with ...

You’re reading a preview, subscribe to read more.

More from Los Angeles Times

Los Angeles Times4 min readAmerican Government
Nuclear Waste Storage At Yucca Mountain Could Roil Nevada US Senate Race
LOS ANGELES -- More than 3.5 million pounds of highly radioactive nuclear waste is buried on a coastal bluff just south of Orange County, California, near an idyllic beach name-checked in the Beach Boys' iconic "Surfin' U.S.A." Spent fuel rods from t
Los Angeles Times4 min read
Geopolitics And The Winner Of This Season's 'RuPaul's Drag Race'
TAIPEI, Taiwan — To hundreds of thousands of fans around the world who watched this season's finale of the hit reality show "RuPaul's Drag Race," the final plea for victory from one of the contestants wasn't especially memorable. "It would mean a lot
Los Angeles Times5 min readPoverty & Homelessness
Monthly Payments Of $1,000 Could Get Thousands Of Homeless People Off The Streets, Researchers Say
LOS ANGELES -- A monthly payment of $750 to $1,000 would allow thousands of the city's homeless people to find informal housing, living in boarding homes, in shared apartments and with family and friends, according to a policy brief by four prominent

Related Books & Audiobooks